APLIF OTC
Appili Therapeutics Inc
1W: -22.2%
1M: +0.0%
3M: -34.5%
YTD: -53.3%
1Y: -50.0%
3Y: -82.5%
5Y: -98.8%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.9M
52W Range0.0066-0.026
Volume22,100
Avg Volume20,314
Beta-0.21
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODon Cilla
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2021-01-08
Websiteappilitherapeutics.com
#21-1344 Summer Street
Halifax, NS B3H 0A8
CA
Halifax, NS B3H 0A8
CA
902-442-4655
About Appili Therapeutics Inc
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Recent Insider Trades
No insider trades found